Using a case-based approach, this course will highlight the pearls and pitfalls in using MRI for staging and follow-up evaluation of patients with rectal cancer. MR pointers on technique, anatomy, accurate staging, and pitfalls to avoid will be discussed and demonstrated on full case examples. In-Training Members will receive a discounted price of $99 after login
The target audience for this activity is radiologists at all training levels are interested in rectal cancer imaging.
Goals and Objectives:
After completing the material in this activity, the learner should be able to:
Perform high-quality MRI of the pelvis for rectal cancer evaluation
Interpret baseline staging MRI for rectal cancer
Interpret post treatment restaging MRI for rectal cancer
Discuss the value of synoptic/templated reports for rectal cancer
Disclosure of Commercial Interest:
ARRS staff involved with this activity have nothing to disclose. Below is a listing of activity's contributors and planners’ disclosures:
G. Whitman has nothing to disclose.
A. Paladin has nothing to disclose.
Mukesh Harisinghani has nothing to disclose.
Marc Gollub has nothing to disclose.
Kartik Jhaveri has nothing to disclose.
David Kim has stock investments in Cellectar and Elucent.
Accreditation Statement The American Roentgen Ray Society (ARRS) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education activities for physicians.
Designation Statement The ARRS designates this educational activity for a maximum of 2 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The American Medical Association has determined that physicians not licensed in the US who participate in this CME activity are eligible for AMA PRA Category 1 Credit(s)™.
Date of issuance: November 30, 2020
Date of expiration: November 29, 2023
Estimated time to complete the activity: 2 hour(s)